Price: 47985.28 INR/Piece
Contains Trastuzumab as an active ingredient, this Canmab Injection is prescribed as a targeted therapy in the treatment of HER2-positive breast cancer. This medicine is available for intravenous infusion use only and effectively works by interfering with HER2 protein production. Owing to its ability of stopping the growth of cancel cells, this medicine is also recommended for use in combination with other medicines for the treatment of certain types of stomach or esophagus cancer in patients.